ArticleJournal of molecular medicine (Berlin, Germany)2008

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells.

Edwin Bremer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.